5 drug(s) with this reaction
8,295 total reports
Bone Pain has been reported as an adverse reaction across 5 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 8,295 adverse event reports mention bone pain in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with bone pain, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have bone pain listed in their FDA adverse event reports, sorted by report count:
In addition to bone pain, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
5 drug(s) manufactured by Amgen Inc have bone pain listed in their FDA adverse event reports: DENOSUMAB, PEGFILGRASTIM, FILGRASTIM, ROMOSOZUMAB-AQQG, ROMIPLOSTIM.
There are a combined 8,295 reports of bone pain across 5 Amgen Inc drug(s) in the FDA adverse event database.